首页> 外文期刊>Endocrine Connections >Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency
【24h】

Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency

机译:维生素D缺乏继发性甲状旁腺功能亢进症的凝血和纤溶

获取原文
           

摘要

Introduction Abnormal coagulation tests have been observed in patients with primary hyperparathyroidism (HPT) suggesting a prothrombotic effect of parathyroid hormone (PTH). Vitamin D deficiency (VIDD) is the most frequent cause of secondary HPT. Aim of our study was to investigate the influence of HPT secondary to moderate-to-severe VIDD and vitamin D replacement on the coagulation and fibrinolysis system. Subjects and methods Prospective cohort study of patients with vitamin D <25?nmol/L with and without HPT, and a control group of patients on vitamin D suppletion. At baseline and after 2 months of vitamin D suppletion (900,000?IU in 2 months), endocrine and coagulation markers were measured. Results 59 patients with VIDD of which 34 had secondary HPT and 36 controls were included. After 2 months of suppletion, vitamin D increased by 399% (VIDD with HPT), 442% (all patients with VIDD) and 6% (controls). PTH decreased by 34% (VIDD with HPT, P ?
机译:引言在原发性甲状旁腺功能亢进症(HPT)患者中观察到异常的凝血试验,提示甲状旁腺激素(PTH)有血栓形成作用。维生素D缺乏症(VIDD)是继发HPT的最常见原因。我们研究的目的是研究中重度VIDD和维生素D替代继发的HPT对凝血和纤溶系统的影响。受试者和方法对有和没有HPT的维生素D <25nmol / L的患者以及对照组补充维生素D的患者进行前瞻性队列研究。在基线和补充维生素D 2个月后(两个月内900,000?IU),测量内分泌和凝血指标。结果纳入59例VIDD患者,其中34例为继发性HPT,36例为对照。补充2个月后,维生素D增加399%(含HPT的VIDD),442%(所有VIDD患者)和6%(对照组)。在对照组中,PTH降低了34%(VIDD伴HPT,P 0.01降低),32%(所有VIDD,P 0.01)并且在对照组中升高8%(P值:<0.01 HPD或所有VIDD患者与对照组进行VIDD)。伴HPT的VIDD患者或所有VIDD患者与对照组相比,PT,aPTT,纤维蛋白原,Von Willebrand因子,VII,VIII和X因子,凝血酶生成,TAFI,凝块溶解时间和d-二聚体的相对变化无差异。讨论由于VIDD引起的继发性HPT没有血栓形成作用。与以前的报告相反,PTH似乎不影响凝血或纤维蛋白溶解,这是重要的,因为VIDD的患病率很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号